Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro
Jie Dong, Xuan Huang, Li-Ping Ma, et al.
Dose-Response (2022) Vol. 20, Iss. 2
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art
Federico Diotallevi, Helena Gioacchini, Edoardo De Simoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4910-4910
Open Access | Times Cited: 39
Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors
Kaitlynne N. Cunningham, David Rosmarin
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 2, pp. 165-186
Closed Access | Times Cited: 34
A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo
Alireza Jafarzadeh, Arash Pour Mohammad, Mina Khosravi, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 10
Management of the refractory vitiligo patient: current therapeutic strategies and future options
Xinju Wang, Wei Wu, Jianru Chen, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy
Xinxin Li, Yifang Sun, Juan Du, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 635-638
Open Access | Times Cited: 20
Etiopathogenesis and Emerging Methods for Treatment of Vitiligo
Tomasz Iwanowski, Karol Kołkowski, Roman Nowicki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9749-9749
Open Access | Times Cited: 20
JAK inhibitors for the treatment of vitiligo
Shintaro Inoue, Tamio Suzuki, Shigetoshi Sano, et al.
Journal of Dermatological Science (2024) Vol. 113, Iss. 3, pp. 86-92
Open Access | Times Cited: 7
A combined spectroscopic and quantum chemical approach to study the molecular interaction between anti-inflammatory drug Hydrocortisone and amino acid l-Phenylalanine
Jyotshna Saikia, Th. Gomti Devi, T. Karlo
Journal of Molecular Structure (2023) Vol. 1286, pp. 135546-135546
Closed Access | Times Cited: 13
Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications
Marcelina Kądziela, Magdalena Kutwin, Paulina Karp, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4919-4919
Open Access | Times Cited: 4
Treatment advances in Vitiligo: An Updated Review
Ishrat Binti Ismail, Yasmeen Jabeen Bhat, Mohd Shurjeel Ul Islam
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 1, pp. 4600-4600
Open Access
Emerging Therapeutic Innovations for Vitiligo Treatment
Weiran Li, Penghao Dong, Guanhua Zhang, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 191-191
Open Access
Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection
Bo Xie, Yuqi Zhu, Yuqing Shen, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 189-206
Closed Access | Times Cited: 11
The IFN‐γ‐CXCL9/CXCL10‐CXCR3 axis in vitiligo: Pathological mechanism and treatment
Hanqing Liu, Yihui Wang, Qianqian Le, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 4
Open Access | Times Cited: 10
Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review
Hyun Jeong Ju, Jung Min Bae
Dermatology (2024) Vol. 240, Iss. 3, pp. 474-486
Open Access | Times Cited: 3
New and Upcoming Drugs for the Treatment of Vitiligo
Seol Hwa Seong, Sang Ho Oh
Annals of Dermatology (2024) Vol. 36, Iss. 4, pp. 197-197
Open Access | Times Cited: 3
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics
Valentina Pala, Simone Ribero, Pietro Quaglino, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7486-7486
Open Access | Times Cited: 7
SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
Martina Morelli, Stefania Madonna, Cristina Albanesi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
New Therapeutic Targets in Vitiligo
Marcelina Kądziela, Magdalena Kutwin, Paulina Karp, et al.
(2024)
Open Access | Times Cited: 1
JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1
Phototherapy in vitiligo
Anuradha Bishnoi, Iltefat Hamzavi
Pigment International (2024) Vol. 11, Iss. 3, pp. 151-166
Open Access | Times Cited: 1
Emerging role of baricitinib in dermatology practice: All we need to know!
S. Dogra, Shikha Shah, Ayush Sharma, et al.
Indian Dermatology Online Journal (2023) Vol. 14, Iss. 2, pp. 153-153
Open Access | Times Cited: 3
Low‐Dose Baricitinib Plus Narrow‐Band Ultraviolet B for the Treatment of Progressive Non‐Segmental Vitiligo: A Prospective, Controlled, Open‐Label Study
Zhonghui Hu, Lu Lu, Jindi Feng, et al.
Pigment Cell & Melanoma Research (2024)
Open Access
Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
Bin Zhou, Jiachen Gui, Tao Wang, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 2933-2944
Open Access
IL32:A novel pro-inflammatory cytokine involved in non-segmental vitiligo pathogenesis
Azza Gaber Antar Farag, Mohamed Shoeib, Ramy Magdy Abd El-Sattar Koutb, et al.
Human Gene (2024) Vol. 39, pp. 201264-201264
Closed Access
Implication of colloidal therapeutics in the treatment of vitiligo: Portray of signaling cascade, current drug-targets and preclinical and clinical evidences
Priti Paul, Harithasree Veerabomma, Ujala Gupta, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105666-105666
Closed Access
Page 1 - Next Page

Scroll to top